Skip to content

A randomized controlled trial of acupuncture in the treatment of ovarian reserve dysfunction

A randomized controlled trial of acupuncture in the treatment of ovarian reserve dysfunction

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005907
Enrollment
Unknown
Registered
2022-04-26
Start date
2022-04-26
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian reserve dysfunction

Interventions

sham acupuncture group:Non acupoint shallow needling

Sponsors

Chengdu Xinan gynecological hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) 20 years = age < 40 years; (2) Meet the diagnostic criteria of ovarian reserve dysfunction; (3) Voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients suffering from severe systemic organic diseases such as heart, liver and kidney, which makes it difficult to achieve pregnancy; (2) Combined with congenital reproductive organ development abnormalities affecting pregnancy, endometrial polyps, hysteromyomas, endometriosis, or other organic diseases. (3) Patients with polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, hypothyroidism, chronic adrenocortical dysfunction and other diseases; (4) Severe wasting disease or developing malignant tumor; (5) Patients with bleeding tendency and prone to infection, or patients with severe allergies, or patients with skin ulcers, scars and other prohibited acupuncture; (6) IVF-ET planners are expected within 2 months after enrollment. Note: patients who meet any of the above conditions should be excluded.

Design outcomes

Primary

MeasureTime frame
antral follicle count;

Secondary

MeasureTime frame
Peak systolic blood flow velocity;Follicle stimulating hormone;embryo implantation rate;early pregnancy loss rate;Self-Rating Anxiety Scale;Anti Mullerian hormone;?????;Clinical pregnancy rate;Luteinizing hormone;Prog;Estradiol;egg number;high-quality embryo rate;Systolic / diastolic blood flow velocity ratio;Available embryo rate;biochemical pregnancy rate;Arterial resistance index;

Countries

China

Contacts

Public Contactyangjie
jenny_yang_jie@126.com13882296714

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026